The Gene Therapy Market, dominated by gene therapies for cancer, is Projected to be Worth USD 10 Billion by 2035 growing at an Annualized Rate of Over 40%. The Roots Analysis report offers a study on the current market landscape and the likely future potential associated with the gene therapy market. It primarily focuses on gene augmentation-based therapies, oncolytic viral therapies, and immunotherapies.